![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||
|
Survival rates for five years are quite similar for all stages when Rice (Figure 2) is compared to the NCDB (National Cancer Data Base-Figure 3). As expected, the survival rates for stage 0 and 1 exceeds 95%; whereas, the rates for stage 3 and 4 range from 45-60%. Treatment for breast cancer usually includes surgery alone or surgery combined with radiation, chemotherapy, and/or hormone therapy. RMH data (Figure 4) again mirrors the NCDB (Figure 5) with only 4-6% receiving a treatment that did not include surgery. Over the past 20 years, the preferred surgery of breast cancer has evolved from the radical mastectomy to more breast conserving surgery such as lumpectomy. Prior to 1990, most surgery of the breast included a total axillary dissection to stage the cancer. A frequent adverse effect of this procedure is upper arm lymphedema. This can range from a mild nuisance to a crippling disability. In order to decrease the incidence of lymphedema, a sentinel lymph node biopsy of the axilla has become the standard of care. In this procedure, dye is injected into the breast and picked up in the regional lymph nodes, and only those lymph nodes that collect this dye are harvested. If these lymph nodes then show cancer, the remainder of the lymph nodes are removed in a total axillary dissection. If they do not show cancer, the rest of the lymph nodes are left alone, and lymphedema is much decreased. Our data shows that nearly 40% of our surgeries include a sentinel node biopsy (Figure 6). From 2000 to 2003, 114 patients have been spared a total axillary dissection and are spared the associated lymphedema. Gordon Bos, M.D. figure 1 figure 2 figure 3 figure 4 figure 5 figure 6
Other Breast Comparisons figure 7 figure 8
figure 9 figure 10
|
||||||||||||||
|
2004
Cancer Committee · Willmar
Cancer Center · About the Cancer Registry Published May 25, 2005
|
||||||||||||||